Guidelines for diagnosis, prevention and treatment of hand eczema: short version

Thomas L Diepgen; Klaus E Andersen; Oliver Chosidow; Peter Jan Coenraads; Peter Elsner; John English; Manigé Fartasch; Ana Gimenez-Arnau; Rosemary Nixon; Denis Sasseville; Tove Agner

doi:10.1111/ddg.12510

Guidelines for diagnosis, prevention and treatment of hand eczema: short version

Thomas L Diepgen, Klaus E Andersen, Oliver Chosidow, Peter Jan Coenraads, Peter Elsner, John English, Manigé Fartasch, Ana Gimenez-Arnau, Rosemary Nixon, Denis Sasseville, Tove Agner

Department of Clinical Medicine

75 Citations (Scopus)

Abstract

The guidelines aim to provide advice on the management of hand eczema (HE), using an evidence- and consensus-based approach. The guidelines consider a systematic Cochrane review on interventions for HE, which is based on a systematic search of the published literature (including hand-searching). In addition to the evidence- and consensus-based recommendation on the treatment of HE, the guidelines cover mainly consensus-based diagnostic aspects and preventive measures (primary and secondary prevention). Treatment recommendations include non-pharmacological interventions, topical, physical and systemic treatments. Topical corticosteroids are recommended as first line treatment in the management of HE, however continuous long-term treatment beyond six weeks only when necessary and under careful medical supervision. Alitretinoin is recommended as a second line treatment (relative to topical corticosteroids) for patients with severe chronic HE. Randomized control trials (RCT) are missing for other used systemic treatments and comparison of systemic drugs in "head-to-head" RCTs are needed. The guidelines development group is a working group of the European Society of Contact Dermatitis (ESCD) and has carefully tried to reconcile opposite views, define current optimal practice and provide specific recommendations, and meetings have been chaired by a professional moderator of the AWMF (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften; Association of the Scientific Medical Societies in Germany). No financial support was given by any medical company. The guidelines are expected to be valid until December 2017 at the latest.

Original language	English
Journal	Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Volume	13
Issue number	1
Pages (from-to)	77-84
Number of pages	8
ISSN	1610-0379
DOIs	https://doi.org/10.1111/ddg.12510
Publication status	Published - 1 Jan 2015

Keywords

Administration, Topical
Adrenal Cortex Hormones
Dermatologic Agents
Dermatology
Eczema
Europe
Evidence-Based Medicine
Germany
Gloves, Protective
Hand Dermatoses
Humans
Practice Guidelines as Topic
Treatment Outcome

Access to Document

10.1111/ddg.12510

Cite this

Diepgen, T. L., Andersen, K. E., Chosidow, O., Coenraads, P. J., Elsner, P., English, J., Fartasch, M., Gimenez-Arnau, A., Nixon, R., Sasseville, D., & Agner, T. (2015). Guidelines for diagnosis, prevention and treatment of hand eczema: short version. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 13(1), 77-84. https://doi.org/10.1111/ddg.12510

Guidelines for diagnosis, prevention and treatment of hand eczema : short version. / Diepgen, Thomas L; Andersen, Klaus E; Chosidow, Oliver et al.

In: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, Vol. 13, No. 1, 01.01.2015, p. 77-84.

Research output: Contribution to journal › Journal article › Research › peer-review

Diepgen, TL, Andersen, KE, Chosidow, O, Coenraads, PJ, Elsner, P, English, J, Fartasch, M, Gimenez-Arnau, A, Nixon, R, Sasseville, D & Agner, T 2015, 'Guidelines for diagnosis, prevention and treatment of hand eczema: short version', Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, vol. 13, no. 1, pp. 77-84. https://doi.org/10.1111/ddg.12510

@article{f9c17f5369834d2dab47056bb50267e8,

title = "Guidelines for diagnosis, prevention and treatment of hand eczema: short version",

abstract = "The guidelines aim to provide advice on the management of hand eczema (HE), using an evidence- and consensus-based approach. The guidelines consider a systematic Cochrane review on interventions for HE, which is based on a systematic search of the published literature (including hand-searching). In addition to the evidence- and consensus-based recommendation on the treatment of HE, the guidelines cover mainly consensus-based diagnostic aspects and preventive measures (primary and secondary prevention). Treatment recommendations include non-pharmacological interventions, topical, physical and systemic treatments. Topical corticosteroids are recommended as first line treatment in the management of HE, however continuous long-term treatment beyond six weeks only when necessary and under careful medical supervision. Alitretinoin is recommended as a second line treatment (relative to topical corticosteroids) for patients with severe chronic HE. Randomized control trials (RCT) are missing for other used systemic treatments and comparison of systemic drugs in {"}head-to-head{"} RCTs are needed. The guidelines development group is a working group of the European Society of Contact Dermatitis (ESCD) and has carefully tried to reconcile opposite views, define current optimal practice and provide specific recommendations, and meetings have been chaired by a professional moderator of the AWMF (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften; Association of the Scientific Medical Societies in Germany). No financial support was given by any medical company. The guidelines are expected to be valid until December 2017 at the latest.",

keywords = "Administration, Topical, Adrenal Cortex Hormones, Dermatologic Agents, Dermatology, Eczema, Europe, Evidence-Based Medicine, Germany, Gloves, Protective, Hand Dermatoses, Humans, Practice Guidelines as Topic, Treatment Outcome",

author = "Diepgen, {Thomas L} and Andersen, {Klaus E} and Oliver Chosidow and Coenraads, {Peter Jan} and Peter Elsner and John English and Manig{\'e} Fartasch and Ana Gimenez-Arnau and Rosemary Nixon and Denis Sasseville and Tove Agner",

note = "{\textcopyright} 2014 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.",

year = "2015",

month = jan,

day = "1",

doi = "10.1111/ddg.12510",

language = "English",

volume = "13",

pages = "77--84",

journal = "JDDG - Journal of the German Society of Dermatology",

issn = "1610-0379",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Guidelines for diagnosis, prevention and treatment of hand eczema

T2 - short version

AU - Diepgen, Thomas L

AU - Andersen, Klaus E

AU - Chosidow, Oliver

AU - Coenraads, Peter Jan

AU - Elsner, Peter

AU - English, John

AU - Fartasch, Manigé

AU - Gimenez-Arnau, Ana

AU - Nixon, Rosemary

AU - Sasseville, Denis

AU - Agner, Tove

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The guidelines aim to provide advice on the management of hand eczema (HE), using an evidence- and consensus-based approach. The guidelines consider a systematic Cochrane review on interventions for HE, which is based on a systematic search of the published literature (including hand-searching). In addition to the evidence- and consensus-based recommendation on the treatment of HE, the guidelines cover mainly consensus-based diagnostic aspects and preventive measures (primary and secondary prevention). Treatment recommendations include non-pharmacological interventions, topical, physical and systemic treatments. Topical corticosteroids are recommended as first line treatment in the management of HE, however continuous long-term treatment beyond six weeks only when necessary and under careful medical supervision. Alitretinoin is recommended as a second line treatment (relative to topical corticosteroids) for patients with severe chronic HE. Randomized control trials (RCT) are missing for other used systemic treatments and comparison of systemic drugs in "head-to-head" RCTs are needed. The guidelines development group is a working group of the European Society of Contact Dermatitis (ESCD) and has carefully tried to reconcile opposite views, define current optimal practice and provide specific recommendations, and meetings have been chaired by a professional moderator of the AWMF (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften; Association of the Scientific Medical Societies in Germany). No financial support was given by any medical company. The guidelines are expected to be valid until December 2017 at the latest.

AB - The guidelines aim to provide advice on the management of hand eczema (HE), using an evidence- and consensus-based approach. The guidelines consider a systematic Cochrane review on interventions for HE, which is based on a systematic search of the published literature (including hand-searching). In addition to the evidence- and consensus-based recommendation on the treatment of HE, the guidelines cover mainly consensus-based diagnostic aspects and preventive measures (primary and secondary prevention). Treatment recommendations include non-pharmacological interventions, topical, physical and systemic treatments. Topical corticosteroids are recommended as first line treatment in the management of HE, however continuous long-term treatment beyond six weeks only when necessary and under careful medical supervision. Alitretinoin is recommended as a second line treatment (relative to topical corticosteroids) for patients with severe chronic HE. Randomized control trials (RCT) are missing for other used systemic treatments and comparison of systemic drugs in "head-to-head" RCTs are needed. The guidelines development group is a working group of the European Society of Contact Dermatitis (ESCD) and has carefully tried to reconcile opposite views, define current optimal practice and provide specific recommendations, and meetings have been chaired by a professional moderator of the AWMF (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften; Association of the Scientific Medical Societies in Germany). No financial support was given by any medical company. The guidelines are expected to be valid until December 2017 at the latest.

KW - Administration, Topical

KW - Adrenal Cortex Hormones

KW - Dermatologic Agents

KW - Dermatology

KW - Eczema

KW - Europe

KW - Evidence-Based Medicine

KW - Germany

KW - Gloves, Protective

KW - Hand Dermatoses

KW - Humans

KW - Practice Guidelines as Topic

KW - Treatment Outcome

U2 - 10.1111/ddg.12510

DO - 10.1111/ddg.12510

M3 - Journal article

C2 - 25640512

SN - 1610-0379

VL - 13

SP - 77

EP - 84

JO - JDDG - Journal of the German Society of Dermatology

JF - JDDG - Journal of the German Society of Dermatology

IS - 1

ER -

Guidelines for diagnosis, prevention and treatment of hand eczema: short version

Abstract

Keywords

Access to Document

Fingerprint

Cite this